FDA Industry Responds to Communication Guidances Thomas Sullivan Aug 29, 2017 0 In early 2017, FDA issued draft question and answer documents detailing how drug and device firms can discuss unapproved medical…
Congress A Murky Future for Off-label Promotion: Off-Label Bills Garner Minimal… Thomas Sullivan Aug 29, 2017 0 Further muddying the off-label waters is the fact that Congress has introduced several bills, attempting to legislate off-label…
